Literature DB >> 21520034

Body mass index and body size in early adulthood and risk of pancreatic cancer in a central European multicenter case-control study.

Kevin Y Urayama1, Ivana Holcatova, Vladimir Janout, Lenka Foretova, Eleonora Fabianova, Zora Adamcakova, Miroslav Ryska, Arnost Martinek, Olga Shonova, Paul Brennan, Ghislaine Scélo.   

Abstract

The relationship between two measures of excess body weight, body mass index (BMI) and body size score, and risk of pancreatic cancer was examined among 574 pancreatic cancer cases and 596 frequency-matched controls from the Czech Republic and Slovakia enrolled between 2004 and 2009. Analyses using multivariable logistic regression showed an increased risk of pancreatic cancer associated with elevated quartiles of BMI at ages 20 [fourth quartile: odds ratio (OR) = 1.79, 95% confidence interval (CI): 1.23, 2.61] and 40 (fourth quartile: OR = 1.57, 95% CI: 1.09, 2.27) compared to the lowest quartile. Consistent results were observed for body size score at ages 20 (high versus low: OR = 1.66, 95% CI: 1.08, 2.57) and 40 (medium versus low: OR = 1.36, 95% CI: 1.00, 1.86), but no association was found for BMI and body size score at 2 years before the interview. Stronger risk estimates for BMI were observed in males than females, particularly at age 20, but the analysis of body size yielded similar estimates by sex. When considering excess body weight at both ages 20 and 40 jointly, the highest risk estimates were observed among subjects with elevated levels at both time periods in the analysis of BMI (OR = 1.86, 95% CI: 1.32, 2.62) and body size (OR = 1.53, 95% CI: 1.09, 2.13). These findings, based on two different measures, provide strong support for an increased risk of pancreatic cancer associated with excess body weight, possibly strongest during early adulthood.
Copyright © 2011 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21520034      PMCID: PMC3146968          DOI: 10.1002/ijc.25959

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  49 in total

Review 1.  Insulin resistance and obesity. The role of fat distribution pattern.

Authors:  N Abate
Journal:  Diabetes Care       Date:  1996-03       Impact factor: 19.112

2.  Anthropometric factors and pancreatic cancer in a population-based case-control study in the San Francisco Bay area.

Authors:  Carey A Eberle; Paige M Bracci; Elizabeth A Holly
Journal:  Cancer Causes Control       Date:  2005-12       Impact factor: 2.506

3.  Obesity before age 30 years and risk of advanced prostate cancer.

Authors:  Whitney R Robinson; June Stevens; Marilie D Gammon; Esther M John
Journal:  Am J Epidemiol       Date:  2005-06-15       Impact factor: 4.897

4.  Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort.

Authors:  Alpa V Patel; Carmen Rodriguez; Leslie Bernstein; Ann Chao; Michael J Thun; Eugenia E Calle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

5.  Obesity and the risk of pancreatic cancer: an italian multicenter study.

Authors:  Raffaele Pezzilli; Antonio Maria Morselli-Labate; Marina Migliori; Marco Manca; Luciana Bastagli; Lucio Gullo
Journal:  Pancreas       Date:  2005-10       Impact factor: 3.327

6.  Body size in different periods of life and breast cancer risk in post-menopausal women.

Authors:  C Magnusson; J Baron; I Persson; A Wolk; R Bergström; D Trichopoulos; H O Adami
Journal:  Int J Cancer       Date:  1998-03-30       Impact factor: 7.396

7.  The association of body mass index and pancreatic cancer in residents of southeastern Michigan, 1996-1999.

Authors:  Jon P Fryzek; Maryjean Schenk; Margaret Kinnard; Joel K Greenson; David H Garabrant
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

8.  A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.

Authors:  M L Rothenberg; M J Moore; M C Cripps; J S Andersen; R K Portenoy; H A Burris; M R Green; P G Tarassoff; T D Brown; E S Casper; A M Storniolo; D D Von Hoff
Journal:  Ann Oncol       Date:  1996-04       Impact factor: 32.976

9.  Body mass index and cancer risk in Korean men and women.

Authors:  Sun Ha Jee; Ji Eun Yun; Eun Jung Park; Eo Rin Cho; Il Su Park; Jae Woong Sull; Heechoul Ohrr; Jonathan M Samet
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

10.  Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles.

Authors:  U Bergmann; H Funatomi; M Yokoyama; H G Beger; M Korc
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

View more
  11 in total

1.  Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC4).

Authors:  Leila Lujan-Barroso; Wei Zhang; Sara H Olson; Yu-Tang Gao; Herbert Yu; Peter A Baghurst; Paige M Bracci; H Bas Bueno-de-Mesquita; Lenka Foretová; Steven Gallinger; Ivana Holcatova; Vladimír Janout; Bu-Tian Ji; Robert C Kurtz; Carlo La Vecchia; Pagona Lagiou; Donghui Li; Anthony B Miller; Diego Serraino; Witold Zatonski; Harvey A Risch; Eric J Duell
Journal:  Pancreas       Date:  2016-11       Impact factor: 3.327

2.  The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study.

Authors:  Robert Carreras-Torres; Mattias Johansson; Valerie Gaborieau; Philip C Haycock; Kaitlin H Wade; Caroline L Relton; Richard M Martin; George Davey Smith; Paul Brennan
Journal:  J Natl Cancer Inst       Date:  2017-09-01       Impact factor: 13.506

Review 3.  Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma.

Authors:  Rachael Z Stolzenberg-Solomon; Laufey T Amundadottir
Journal:  Hematol Oncol Clin North Am       Date:  2015-08       Impact factor: 3.722

4.  Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium.

Authors:  C Bosetti; V Rosato; D Li; D Silverman; G M Petersen; P M Bracci; R E Neale; J Muscat; K Anderson; S Gallinger; S H Olson; A B Miller; H Bas Bueno-de-Mesquita; G Scelo; V Janout; I Holcatova; P Lagiou; D Serraino; E Lucenteforte; E Fabianova; P A Baghurst; W Zatonski; L Foretova; E Fontham; W R Bamlet; E A Holly; E Negri; M Hassan; A Prizment; M Cotterchio; S Cleary; R C Kurtz; P Maisonneuve; D Trichopoulos; J Polesel; E J Duell; P Boffetta; C La Vecchia; P Ghadirian
Journal:  Ann Oncol       Date:  2014-07-23       Impact factor: 32.976

5.  Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort.

Authors:  Rachael Z Stolzenberg-Solomon; Catherine Schairer; Steve Moore; Albert Hollenbeck; Debra T Silverman
Journal:  Am J Clin Nutr       Date:  2013-08-28       Impact factor: 7.045

6.  The effect of the macronutrient composition of breakfast on satiety and cognitive function in undergraduate students.

Authors:  Christine H Emilien; Robert West; James H Hollis
Journal:  Eur J Nutr       Date:  2016-07-05       Impact factor: 5.614

7.  Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.

Authors:  Erica J Childs; Evelina Mocci; Daniele Campa; Paige M Bracci; Steven Gallinger; Michael Goggins; Donghui Li; Rachel E Neale; Sara H Olson; Ghislaine Scelo; Laufey T Amundadottir; William R Bamlet; Maarten F Bijlsma; Amanda Blackford; Michael Borges; Paul Brennan; Hermann Brenner; H Bas Bueno-de-Mesquita; Federico Canzian; Gabriele Capurso; Giulia M Cavestro; Kari G Chaffee; Stephen J Chanock; Sean P Cleary; Michelle Cotterchio; Lenka Foretova; Charles Fuchs; Niccola Funel; Maria Gazouli; Manal Hassan; Joseph M Herman; Ivana Holcatova; Elizabeth A Holly; Robert N Hoover; Rayjean J Hung; Vladimir Janout; Timothy J Key; Juozas Kupcinskas; Robert C Kurtz; Stefano Landi; Lingeng Lu; Ewa Malecka-Panas; Andrea Mambrini; Beatrice Mohelnikova-Duchonova; John P Neoptolemos; Ann L Oberg; Irene Orlow; Claudio Pasquali; Raffaele Pezzilli; Cosmeri Rizzato; Amethyst Saldia; Aldo Scarpa; Rachael Z Stolzenberg-Solomon; Oliver Strobel; Francesca Tavano; Yogesh K Vashist; Pavel Vodicka; Brian M Wolpin; Herbert Yu; Gloria M Petersen; Harvey A Risch; Alison P Klein
Journal:  Nat Genet       Date:  2015-06-22       Impact factor: 38.330

8.  KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control.

Authors:  Florence Le Calvez-Kelm; Matthieu Foll; Magdalena B Wozniak; Tiffany M Delhomme; Geoffroy Durand; Priscilia Chopard; Maroulio Pertesi; Eleonora Fabianova; Zora Adamcakova; Ivana Holcatova; Lenka Foretova; Vladimir Janout; Maxime P Vallee; Sabina Rinaldi; Paul Brennan; James D McKay; Graham B Byrnes; Ghislaine Scelo
Journal:  Oncotarget       Date:  2016-11-29

9.  Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA.

Authors:  Maria Zvereva; Gabriel Roberti; Geoffroy Durand; Catherine Voegele; Minh Dao Nguyen; Tiffany M Delhomme; Priscilia Chopard; Eleonora Fabianova; Zora Adamcakova; Ivana Holcatova; Lenka Foretova; Vladimir Janout; Paul Brennan; Matthieu Foll; Graham B Byrnes; James D McKay; Ghislaine Scelo; Florence Le Calvez-Kelm
Journal:  EBioMedicine       Date:  2020-04-03       Impact factor: 8.143

10.  Overweight or Obese Individuals at Eighteen Years of Age Develop Pancreatic Adenocarcinoma at a Significantly Earlier Age.

Authors:  David T Chao; Nilesh H Shah; Herbert J Zeh; Aatur D Singhi; Nathan Bahary; Kevin M McGrath; Kenneth E Fasanella; Amer H Zureikat; David C Whitcomb; Randall E Brand
Journal:  Gastroenterol Res Pract       Date:  2018-06-05       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.